H-1B Filings
25
DOL labor condition applications on file
Management of Companies MA
Alexion Pharmaceuticals, Inc. — Workforce Profile
Federal-records workforce intelligence for Alexion Pharmaceuticals, Inc. (MA) — H-1B labor condition applications, OSHA injury and illness records, and WARN Act mass-layoff disclosures, fused into one transparent profile.
Median H-1B Salary
$172,895
Across 24 disclosed positions
OSHA Safety Grade
Grade A · DART 0.09
Industry avg DART 0.33
Layoff Stability
0 WARN notices
Clean record in state workforce filings
Government Data Summary
| Field | Value | Source |
|---|---|---|
| Employer Name | Alexion Pharmaceuticals, Inc. | DOL OFLC / OSHA / WARN |
| Industry | Management of Companies | NAICS / DOL |
| State | MA | U.S. Federal Records |
| H-1B Filings | 25 | DOL OFLC LCA Disclosure |
| H-1B Median Salary | $172,895 | DOL OFLC LCA Disclosure |
| OSHA Safety Grade | A | OSHA ITA |
| OSHA DART Rate | 0.09 | OSHA ITA Establishment Records |
| WARN Layoff Notices | No WARN notices | WARN Act notices, state workforce agency originals (archival backstop: LayoffData.com) |
Compiled from public records. Federal employer data is reported per OFFCP / EEOC compliance frameworks; values reflect the most recent disclosure period available.
H-1B Salary Data
| Job Title | Median |
|---|---|
| Director, Commercial Data Analytics and Reporting | $255,000 |
| Director, Commercial Data Analytics and Reporting | $255,000 |
| Director, CMC Team Lead | $228,776 |
| Director, CMC Team Lead | $228,776 |
| Director, Study Start-Up and Site Partnerships | $228,000 |
| Associate Director, Clinical Supply Lead | $195,000 |
| Associate Director, Clinical Supply Lead | $195,000 |
| Associate Director Development Asset Quality Meta | $194,324 |
| Associate Director, AI Diagnostics | $190,000 |
| Principal Engineer, Biologics Drug Substance Tech. Transfer | $176,000 |
| Regulatory Publishing Manager | $170,100 |
| Regulatory Publishing Manager | $170,100 |
| Principal Engineer, Biologics Drug Substance Tech. Transfer | $170,000 |
| Senior Manager, Data Analytics and Insights | $164,815 |
| Senior Manager, Quality Management System Analytics | $163,613 |
| Sr Scientist, Process Analytical Technologies & Chemometrics | $155,000 |
| Senior Engineer II, Injectable Drug Product Development | $145,000 |
| Scientist II | $141,008 |
| Development Scientist II, Analytical Dev & Clinical QC | $139,797 |
| Sr. Scientist I, Analytical Development and Clinical Supply | $135,000 |
| Development Scientist I, Analytical Dvlpmt and Clinical QC | $130,625 |
| Senior Engineer, Biologics Drug Substance Tech Transfer | $128,238 |
| Scientist I, Injectables Drug Product Development | $121,293 |
| Associate Scientist III, Upstream Process Development | $96,900 |
What the Data Says About Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. operating in MA within the Management of Companies sector appears across multiple federal and state datasets that every job seeker, investigative reporter, and compliance researcher should know about. The company has filed 25 H-1B labor condition applications with a median disclosed wage of $172,895. Records here combine U.S. Department of Labor disclosures and state workforce agency filings. Each row on this page is sourced directly from a public government record, not a paid vendor or crowd-sourced review site, so the numbers reflect legally filed disclosures rather than opinion.
On workplace safety, Alexion Pharmaceuticals, Inc. posted a DART (Days Away, Restricted, Transferred) rate of 0.09 injuries per 100 full-time workers, compared with an industry peer average of 0.33. Our composite grade of "A" translates that raw rate into a relative benchmark so a job seeker can compare a hospital chain to a warehouse or a bank to a food processor without chasing down OSHA formulas. Across all years on file, OSHA logged 3 reportable injuries at this employer.
No WARN Act mass-layoff notices are currently on file for Alexion Pharmaceuticals, Inc. in the state workforce records we track. That absence is a meaningful positive signal for workforce stability — not a guarantee, since smaller layoffs that fall below WARN thresholds (typically 50 to 500 workers depending on site and state) don't trigger a notice, but still a cleaner record than many peers in the same industry. Cross-reference this profile with the matching industry and metro pages on PlainEmployers to see how Alexion Pharmaceuticals, Inc. benchmarks against nearby employers on wages, safety, and overall workforce stability; every number flows from the same federal and state datasets and refreshes on a known ETL schedule.
OSHA Safety Record
Grade A DART Rate: 0.09 (Industry Avg: 0.33)
This employer DART rate (lower is safer)
Industry average
Days Away, Restricted, or Transferred rate per 100 full-time workers. Source: OSHA Injury & Illness data.
Total reported injuries on file: 3.
How Alexion Pharmaceuticals, Inc. compares to Management of Companies peers
Top H-1B-filing employers in the same NAICS sector. Peer cards link to their own federal-records profile.
Alexion Pharmaceuticals, Inc.
25 H-1B filings
JPMorgan Chase & Co.
1,353 H-1B filings
Micron Technology, Inc.
159 H-1B filings
Related
Data sourced from official federal and state workforce datasets (DOL H-1B, OSHA ITA, state WARN notices). See our methodology for details. Retrieved and formatted by Kiznis Studio Editorial
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from OSHA and the DOL Wage and Hour Division. Consult a qualified professional before making decisions based on this data.
Learn more: Safety Grades Explained | H-1B Salary Negotiation
Read our methodology — how this data is sourced, computed, and verified.